Canada inched ahead of the United States on new daily coronavirus cases per capita and officials warned that worse is to come.
Tag: Pfizer Inc
Changing Strategy, E.U. Bets Big on Pfizer to Battle Covid
After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for a faster rollout of the Pfizer-BioNTech shot.
European Union Promises Extra Covid-19 Vaccine Doses From Pfizer
The bloc will receive an extra 50 million doses from the manufacturer this month as it moves away from relying on vaccines from AstraZeneca and Johnson & Johnson.
My Family’s Global Vaccine Journey
We were spread across three continents, at the mercy of vaccine geopolitics. Which of us would be inoculated last?
Pfizer Requests Authorization to Use Vaccine in Young Teens
If the emergency use authorization is broadened, young adolescents could start getting vaccinated before going back to school in the fall.
Kati Kariko Helped Shield the World From the Coronavirus
Collaborating with devoted colleagues, Dr. Kariko laid the groundwork for the mRNA vaccines turning the tide of the pandemic.
Possible Side Effects of AstraZeneca Vaccine Come Into Sharper Focus
Regulators may soon issue their first formal warnings about rare blood clots, threatening to cloud the global rollout of a cheap and easy-to-store vaccine.
The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents
A clinical trial found no symptomatic infections among vaccinated children ages 12 to 15, the companies said, and there were no serious side effects. The data have not yet been reviewed by independent experts.
Moderna and Pfizer-BioNTech Vaccines Are Very Effective, Report Says
Consistent with clinical trial data, a two-dose regimen prevented 90 percent of infections by two weeks after the second shot. One dose prevented 80 percent of infections by two weeks after vaccination.